PAION initiated a dedicated safety study of Remimazolam in American Society of Anesthesiologists classification III to IV patients undergoing colonoscopy as part of the U.S. Phase III program.
EndoGastric Solutions secured additional financing of up to $50 million.
Olympus launched EZDilate multi-stage endoscopic balloon dilator.
More articles on GI/endoscopy:
CMS bumps up payments for incomplete colonoscopies: 3 key points
New PAION study focuses on use of Remimazolam in high-risk colonoscopy patients: 4 things to know
GI physician leader to know: Dr. Kalpesh Thakkar of Memorial Hermann Medical Group
